Levels of LDL cholesterol, the so-called "bad cholesterol" that blocks arteries, have been found to be 20% higher immediately after Christmas compared to the summer. A leading testing expert is warning this could lead to ...
Jan 6, 2023
0
4
Nearly half of heart disease patients have insomnia, according to research presented at ESC Preventive Cardiology 2022, a scientific congress of the European Society of Cardiology (ESC), and published in SLEEP Advances.
Apr 7, 2022
0
4
Compared with a placebo, the addition of the injectable cholesterol-lowering drug alirocumab to high-intensity statin treatment in patients who have had a heart attack resulted in twofold greater reductions in three key measures ...
Apr 4, 2022
0
13
In a new paper detailing findings from North Carolina State University's GenX Exposure Study, researchers found that elevated levels of per- and polyfluoroalkyl substances (PFAS) were associated with higher total cholesterol ...
Sep 7, 2022
0
17
Next to water, tea is one of the most popular beverages in the world, and at just a couple of calories per serving, it's loaded with flavonoids that make it one of the world's healthiest beverages as well.
Dec 14, 2020
0
7
The risk of cardiovascular diseases, including myocardial infarction and stroke, has been shown to be roughly twice as high in people living with HIV than the general population, creating an urgent need to test prevention ...
Jul 24, 2023
0
37
The consumption of millets can reduce total cholesterol, triacylglycerols (commonly known as triglycerides) and BMI according to a new study that analyzed the data of 19 studies with nearly 900 people. The latest study was ...
Aug 18, 2021
0
30
Among patients with atherosclerotic cardiovascular disease (ASCVD), high-intensity statins are underutilized in routine care, according to a study published online Aug. 2 in Circulation: Cardiovascular Quality and Outcomes.
Sep 19, 2023
0
0
A drug used to manage diabetes may reduce heart disease and death in people with diabetes regardless of their cholesterol levels and whether they are on a statin therapy, suggests a new analysis of the LEADER trial.
Aug 27, 2018
0
2
A new medication, pemafibrate, lowered triglyceride levels among adults with type 2 diabetes yet did not decrease their cardiovascular risk, according to late-breaking science research presented today at the American Heart ...
Nov 7, 2022
0
18
